There are some significant side effects to remember if you use a GLP-1 agonist for weight loss, including the following: Nausea Vomiting Diarrhea Constipation Stomach fullness Hypoglycemia (low blood sugar) Pancreatitis Gallbladder disorders Cancer risk Gastroparesis (delayed stomach emptying) Intestinal blockage Aspiration (food or liquids entering the lungs), especially if you have to be sedated for surgery Psychiatric effects, including anxiety, eating disorders, and trouble sleeping Hypersensitivity reactions, including life-threatening anaphylaxis If you develop these side effects, contact your healthcare provider or seek emergency medical care when needed
Even delivery methods are evolving, with GLP-1 patches and oral tirzepatide potentially eliminating the need for syringe conversions altogether
Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells
Whats better: Cagrilintide alone or with semaglutide
marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]
Hemorrhoids are not listed as a recognized adverse effect of tirzepatide in the product labeling, and the pivotal SURMOUNT clinical trials did not identify hemorrhoids as a specific safety signal